Clinical, Cosmetic and Investigational Dermatology (Oct 2019)
Current Insights Into The Management Of Discoid Lupus Erythematosus
Abstract
Jaime Company-Quiroga,* Sergio Alique-García,* Alberto Romero-MatéDermatology Department, Fuenlabrada Univesity Hospital, Madrid, Spain*These authors contributed equally to this workCorrespondence: Jaime Company-QuirogaDermatology Department, Fuenlabrada Univesity Hospital, Camino del Molino 2, Fuenlabrada, Madrid 28942, SpainEmail [email protected]: Discoid lupus erythematosus is the most disfiguring and common presentation of chronic cutaneous lupus erythematosus. Although most patients will respond to lifestyle measures and topical treatment, a non-negligible number of patients will require systemic and physical therapy, either alone or in combination. We performed a review of the available evidence on the discoid lupus erythematosus treatment. Lifestyle measures and topical treatment (corticosteroids and topical calcineurin inhibitors) remain the therapeutic strategies with the highest evidence level. Within systemic treatment approaches, antimalarial drugs are still the first-line therapy, while other systemic and physical therapies have highly variable evidence. Hence, we propose a therapeutic algorithm based on the strength of recommendations of the different treatment modalities, focusing on the refractory disease.Keywords: discoid lupus erythematosus, cutaneous lupus erythematosus, disease management
